Teresa Brevini

Statistics

Publications

Citations

2.2K

H-Index

Active since

1998

Affiliations

Wellcome/MRC Cambridge Stem Cell Institute(Current)

Cambridge University Hospitals NHS Foundation Trust

University of Cambridge

Wellcome Sanger Institute

University of Oslo

Teresa Brevini is an author at Wellcome/MRC Cambridge Stem Cell Institute specializing in sars-cov-2 infection, antiviral therapy, and infectious diseases.

ORCID

Publications per year

1998–2024

Publications

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Bo Meng, Adam Abdullahi, Isabella A.T.M. Ferreira et al. · Nature · 2022 · 1.2K citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Cholangiocyte organoids can repair bile ducts after transplantation in the human liver

Fotios Sampaziotis, Daniele Muraro, Olivia Tysoe et al. · Science · 2021 · 375 citations · Full text

Medicine, Cell Biology, Surgery +17

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2

Teresa Brevini, Mailis Maes, Gwilym J. Webb et al. · Nature · 2022 · 294 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Isolation and propagation of primary human cholangiocyte organoids for the generation of bioengineered biliary tissue

Olivia Tysoe, Alexander W. Justin, Teresa Brevini et al. · Nature Protocols · 2019 · 122 citations · Full text

Engineering, Bioengineering, Cell Biology +14

SARS-CoV-2 Omicron spike mediated immune escape and tropism shift

Bo Meng, Isabella A.T.M. Ferreira, Adam Abdullahi et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 64 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

1–5 of 10